Effective treatment of oxaliplatin-induced cumulative polyneuropathy with alpha-lipoic acid

被引：54

作者：

Gedlicka, C ^{[1
]}

Scheithauer, W ^{[1
]}

Schüll, B ^{[1
]}

Kornek, GV ^{[1
]}

机构：

[1] Univ Vienna, Sch Med, A-1010 Vienna, Austria

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2002年 / 20卷 / 15期

关键词：

D O I：

10.1200/JCO.2002.99.502

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：3359 / 3361

页数：3

共 10 条

[1] Oxaliplatin - A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies [J].

Culy, CR ;

Clemett, D ;

Wiseman, LR .

DRUGS, 2000, 60 (04) :895-924

[2] Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].

de Gramont, A ;

Figer, A ;

Seymour, M ;

Homerin, M ;

Hmissi, A ;

Cassidy, J ;

Boni, C ;

Cortes-Funes, H ;

Cervantes, A ;

Freyer, G ;

Papamichael, D ;

Le Bail, N ;

Louvet, C ;

Hendler, D ;

de Braud, F ;

Wilson, C ;

Morvan, F ;

Bonetti, A .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947

[3] Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer [J].

Giacchetti, S ;

Perpoint, B ;

Zidani, R ;

Le Bail, N ;

Faggiuolo, R ;

Focan, C ;

Chollet, P ;

Llory, JF ;

Letourneau, Y ;

Coudert, B ;

Bertheaut-Cvitkovic, F ;

Larregain-Fournier, D ;

Le Rol, A ;

Walter, S ;

Adam, R ;

Misset, JL ;

Lévi, F .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) :136-147

[4] Oxaliplatin in practice [J].

Misset, JL .

BRITISH JOURNAL OF CANCER, 1998, 77 (Suppl 4) :4-7

[5] LIPOIC ACID IMPROVES NERVE BLOOD-FLOW, REDUCES OXIDATIVE STRESS, AND IMPROVES DISTAL NERVE-CONDUCTION IN EXPERIMENTAL DIABETIC NEUROPATHY [J].

NAGAMATSU, M ;

NICKANDER, KK ;

SCHMELZER, JD ;

RAYA, A ;

WITTROCK, DA ;

TRITSCHLER, H ;

LOW, PA .

DIABETES CARE, 1995, 18 (08) :1160-1167

[6] Alpha-lipoic acid: Antioxidant potency against lipid peroxidation of neural tissues in vitro and implications for diabetic neuropathy [J].

Nickander, KK ;

McPhee, BR ;

Low, PA ;

Tritschler, H .

FREE RADICAL BIOLOGY AND MEDICINE, 1996, 21 (05) :631-639

[7] Subcutaneous administration of amifostine: A promising therapeutic option in patients with oxaliplatin-related peripheral sensitive neuropathy [J].

Penz, M ;

Kornek, GV ;

Raderer, M ;

Ulrich-Pur, H ;

Fiebiger, W ;

Scheithauer, W .

ANNALS OF ONCOLOGY, 2001, 12 (03) :421-422

[8]

Scheithauer W, 2001, CANCER-AM CANCER SOC, V91, P1264, DOI 10.1002/1097-0142(20010401)91:7<1264::AID-CNCR1127>3.0.CO

[9]

2-X

[10] Treatment of symptomatic diabetic polyneuropathy with the antioxidant α-lipoic acid -: A 7-month multicenter randomized controlled trial (ALADIN III Study) [J].

Ziegler, D ;

Hanefeld, M ;

Rahnau, KJ ;

Hasche, H ;

Lobisch, M ;

Schütte, K ;

Kerum, G ;

Malessa, R .

DIABETES CARE, 1999, 22 (08) :1296-1301

← 1 →